Pregnancy in diabetes: reducing the risks.
Meticulous glucose control that begins long before conception is fundamental to protecting the fetus and mother. Maternal hypertension, retinopathy, renal disease, and neuropathy may lead to complications, but optimal education, care, and fetal monitoring can reduce the risks.
Gabbe
S G
SG
Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus.
D000328:Adult; D000465:Algorithms; D000959:Antihypertensive Agents / Q000627:therapeutic use; D015190:Blood Glucose Self-Monitoring; D002585:Cesarean Section; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D003928:Diabetic Nephropathies / Q000150:complications; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D005323:Fetal Monitoring; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007231:Infant, Newborn; D007328:Insulin / Q000008:administration & dosage; D008297:Male; D011225:Pre-Eclampsia / Q000175:diagnosis; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D011254:Pregnancy in Diabetics / Q000628:therapy*; D018566:Pregnancy, High-Risk; D011295:Prenatal Care / Q000379:methods
D000959:Antihypertensive Agents; D007328:Insulin; D004921:Erythropoietin